SecSonar.com

Omnicell, Inc. (OMCL)

Omnicell, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Omnicell, Inc. (OMCL) is a Medical - Healthcare Information Services company based in US with a market capitalization of $2B. Revenue grew 6.5% year-over-year and the company generated $86.9M in free cash flow. This page tracks OMCL's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 3.62K employees · IPO Aug 9, 2001

Valuation

Valuation & price

$43.12 · as of May 17, 2026 · -16.1% vs 52w high

974.2

P/E ratio

Latest-FY diluted EPS

1.64

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$51.19$39.21$27.24Jul 25Dec 25Jul 26Jul 7, 25$28.92Jul 9, 25$29.94Jul 11, 25$28.69Jul 15, 25$27.24Jul 17, 25$27.97Jul 21, 25$28.03Jul 23, 25$28.20Jul 25, 25$28.27Jul 29, 25$29.62Jul 31, 25$31.01Aug 4, 25$30.42Aug 6, 25$31.09Aug 11, 25$30.83Aug 13, 25$31.34Aug 15, 25$31.69Aug 19, 25$31.91Aug 21, 25$31.89Aug 25, 25$33.09Aug 27, 25$33.23Aug 29, 25$32.59Sep 3, 25$32.82Sep 5, 25$32.11Sep 9, 25$32.77Sep 11, 25$33.28Sep 16, 25$32.32Sep 18, 25$31.80Sep 22, 25$31.62Sep 24, 25$30.88Sep 26, 25$30.72Sep 30, 25$30.45Oct 2, 25$29.98Oct 6, 25$30.52Oct 8, 25$31.45Oct 10, 25$29.72Oct 14, 25$29.69Oct 16, 25$30.30Oct 21, 25$30.98Oct 23, 25$30.89Oct 27, 25$30.54Oct 29, 25$29.57Oct 31, 25$33.57Nov 4, 25$34.50Nov 6, 25$35.76Nov 10, 25$36.81Nov 12, 25$36.86Nov 14, 25$35.12Nov 18, 25$34.42Nov 20, 25$34.32Nov 25, 25$37.00Nov 28, 25$36.51Dec 2, 25$38.46Dec 4, 25$39.61Dec 8, 25$43.55Dec 10, 25$43.97Dec 12, 25$43.86Dec 16, 25$44.74Dec 18, 25$46.25Dec 22, 25$45.70Dec 24, 25$45.78Dec 29, 25$46.14Jan 2, 26$45.14Jan 6, 26$47.07Jan 8, 26$50.59Jan 12, 26$51.19Jan 14, 26$50.72Jan 16, 26$50.52Jan 21, 26$50.48Jan 23, 26$50.30Jan 27, 26$49.96Jan 29, 26$49.09Feb 2, 26$48.70Feb 4, 26$46.69Feb 9, 26$36.50Feb 11, 26$37.82Feb 13, 26$36.50Feb 18, 26$38.61Feb 20, 26$40.26Feb 24, 26$40.15Feb 26, 26$41.93Mar 2, 26$41.25Mar 4, 26$41.53Mar 6, 26$41.30Mar 10, 26$38.99Mar 12, 26$35.10Mar 17, 26$35.09Mar 19, 26$33.40Mar 23, 26$34.31Mar 25, 26$34.94Mar 27, 26$32.75Mar 31, 26$33.38Apr 2, 26$34.15Apr 7, 26$34.50Apr 9, 26$35.47Apr 13, 26$35.01Apr 15, 26$37.53Apr 17, 26$38.28Apr 22, 26$36.65Apr 24, 26$37.37Apr 28, 26$45.51Apr 30, 26$41.42May 4, 26$43.44May 6, 26$43.76May 8, 26$43.82May 12, 26$43.70May 14, 26$43.80May 18, 26$43.22May 20, 26$44.72May 22, 26$44.41May 28, 26$44.72Jun 1, 26$43.16Jun 3, 26$41.89Jun 5, 26$43.00Jun 9, 26$40.69Jun 11, 26$37.82Jun 15, 26$39.99Jun 17, 26$38.50Jun 22, 26$38.68Jun 24, 26$39.49Jun 26, 26$40.13Jul 2, 26$43.03
$26.8852-week range$51.39
Loading valuation history…

Fundamentals

Key fundamentals

$2B

Market cap

6.5%

Revenue growth (YoY)

42.9%

Gross margin

$86.9M

Free cash flow (USD)

$7.8M

Net debt

-0.2%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$692.6MFY 2017$716.2MFY 2018$787.3MFY 2019$897.0MFY 2020$892.2MFY 2021$1.1BFY 2022$1.3BFY 2023$1.1BFY 2024$1.1BFY 2025$1.2B
$692.6M$1.2B

Free cash flow by year

2016 → 2025

FY 2016$18.8MFY 2017$-5.7MFY 2018$49.6MFY 2019$83.3MFY 2020$131.0MFY 2021$202.8MFY 2022$17.0MFY 2023$139.6MFY 2024$151.3MFY 2025$86.9M
$18.8M$86.9M

Gross margin by year

2021 → 2025

FY 202149.0%FY 202245.5%FY 202343.6%FY 202442.4%FY 202542.9%
49.0%42.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

2

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventPresident AppointmentJul 1, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 26, 2026Filing
  • Insider sellInsider Sell $217K · 10b5-1 PlanManley Corey J · EVP&CHIEF LEGAL/ADMIN OFFICER · $217.2KMay 19, 2026Filing
  • Insider sellInsider Sell $134K · 10b5-1 PlanNjoku Nnamdi · EVP, Chief Operating Officer · $133.5KMay 19, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing
  • 8-K eventEarnings ReleaseApr 28, 2026Filing

Questions

Frequently asked questions

What is Omnicell, Inc.'s market cap?

Omnicell, Inc. (OMCL) has a market capitalization of $2B.

What is OMCL's P/E ratio?

OMCL trades at a price-to-earnings ratio of 974.2, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is OMCL's price-to-book (P/B) ratio?

OMCL trades at 1.64 times book value per share.

Are insiders buying OMCL stock?

SEC Form 4 filings show no open-market insider buys at Omnicell, Inc. in the last 90 days (2 sells).

Same arena

Related companies in Medical - Healthcare Information Services

PGNY

Progyny, Inc.

$2B

WGS

GeneDx Holdings Corp.

$1.5B

TDOC

Teladoc Health, Inc.

$1.4B

PRVA

Privia Health Group, Inc.

$2.7B

HTFL

Heartflow, Inc. Common Stock

$2.7B

SDGR

Schrödinger, Inc.

$1.1B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.